TNFRSF10B and cancer: Canonical DR5 signaling leads to activation of the extrinsic pathway of apoptosis and has been an attractive therapeutic target for the treatment of cancer due to its ability to selectively induce apoptosis in transformed cells, whereas other cells tend to be resistant to TRAIL-induced apoptosis (18).